Mats Heyman
Clinical trials sponsored by Mats Heyman, explained in plain language.
-
Major trial aims to Fine-Tune leukemia treatment for thousands
Disease control Recruiting nowThis large European study aims to improve survival and reduce side effects for children and young adults (ages 0-45) newly diagnosed with acute lymphoblastic leukemia (ALL). It will test whether treatment can be safely reduced for some patients and whether adding newer drugs can …
Phase: PHASE3 • Sponsor: Mats Heyman • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Nations unite in fight against childhood leukemia with new personalized treatment plan
Disease control Recruiting nowThis study aims to improve survival and quality of life for children and young adults (ages 0-45) newly diagnosed with acute lymphoblastic leukemia (ALL). It brings together leading European research groups to test a new, personalized treatment plan that adjusts therapy based on …
Sponsor: Mats Heyman • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC